Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
State of Tennessee Treasury Department Buys 102,834 Shares of Exelixis, Inc. (NASDAQ:EXEL)
10:08am, Sunday, 28'th Jun 2020
State of Tennessee Treasury Department grew its stake in shares of Exelixis, Inc. (NASDAQ:EXEL) by 72.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Se
3 Biotech Stocks I’d Buy Right Now | The Motley Fool
10:26am, Saturday, 27'th Jun 2020
These companies have products, products, and more products to keep revenue flowing.
Exelixis, Inc. (EXEL) CEO Mike Morrissey at BofA Securities Napa Biopharma Conference Call - (Transcript)
06:29am, Thursday, 25'th Jun 2020
Exelixis, Inc. (NASDAQ:EXEL) BofA Securities Napa Biopharma Conference Call June 24, 2020 3:30 P.M. ET Company Participants Mike Morrissey - President and Chief
Exelixis, Inc. (EXEL) Presents at BMO Capital Markets Prescription for Success Healthcare Broker Conference Call - (Transcript)
09:59pm, Tuesday, 23'rd Jun 2020
Exelixis, Inc. (NASDAQ:EXEL) BMO Capital Markets Prescription for Success Healthcare Conference June 23, 2020, 16:00 ET Company Participants Michael Morrissey -
Exelixis (EXEL) in Focus: Stock Moves 7.6% Higher
03:02am, Tuesday, 23'rd Jun 2020
Exelixis (EXEL) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Innovatus Appoints Geoffrey Duyk, M.D., Ph.D. to Its Life Sciences Advisory Board | | IT Business Net
12:01pm, Monday, 22'nd Jun 2020
NEW YORK--(BUSINESS WIRE)--Innovatus Capital Partners, LLC ("Innovatus" or the "Firm"), an independent adviser and portfolio management firm with approximately $1.6 billion in asse
Victory Capital Management Inc. Reduces Stock Position in Exelixis, Inc. (NASDAQ:EXEL)
04:47am, Monday, 22'nd Jun 2020
Victory Capital Management Inc. lowered its stake in Exelixis, Inc. (NASDAQ:EXEL) by 36.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Innovatus Appoints Geoffrey Duyk, M.D., Ph.D. to Its Life Sciences Advisory Board
12:00am, Monday, 22'nd Jun 2020
Innovatus Capital Partners, LLC (
Exelixis to Webcast Virtual Fireside Chat as Part of the BofA Securities Napa Biopharma Conference on June 24, 2020
08:05pm, Thursday, 18'th Jun 2020
Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will participate in a fireside chat as part of the virtual BofA S
Massachusetts Financial Services Co. MA Sells 22,411 Shares of Exelixis, Inc. (NASDAQ:EXEL)
08:40am, Thursday, 18'th Jun 2020
Massachusetts Financial Services Co. MA lowered its position in Exelixis, Inc. (NASDAQ:EXEL) by 68.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC.
Parametric Portfolio Associates LLC Has $8.05 Million Stake in Exelixis, Inc. (NASDAQ:EXEL)
07:45am, Thursday, 18'th Jun 2020
Parametric Portfolio Associates LLC increased its position in Exelixis, Inc. (NASDAQ:EXEL) by 12.6% during the first quarter, according to the company in its most recent 13F filing with the Securities
Exelixis to Webcast Virtual Fireside Chat as Part of the BofA Securities Napa Biopharma Conference on June 24, 2020
12:00am, Thursday, 18'th Jun 2020
Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will participate
3 Stocks Growing Capex Fast
05:42pm, Wednesday, 17'th Jun 2020
Large spending to improve fixed assets may anticipate growth Continue reading...
Biotech ETFs: Appraising The Pipelines
12:00am, Wednesday, 17'th Jun 2020
Parsing the performance and holdings of different biotech funds.
Viela Bio Gets Approval And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:VIE)
09:13am, Tuesday, 16'th Jun 2020
Viela Bio receives FDA approval for Uplizna. Exelixis starts late stage lung cancer study. Agios reports positive proof of concept study.
